Skip to main content
logo
Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
22.30
-1.07 (-4.58%)
At close: Mar 20, 2026, 4:00 PM EDT
22.63
+0.33 (1.48%)
After-hours: Mar 20, 2026, 5:07 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Research and Development of Precision Immunology-Based Therapies
10.00M5.00M50.00M
Research and Development of Precision Immunology-Based Therapies Growth
100.00%-90.00%-
Total
10.00M5.00M50.00M
Total Growth
100.00%-90.00%-

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
United States
10.00M5.00M50.00M
United States Growth
100.00%-90.00%-
Total
10.00M5.00M50.00M
Total Growth
100.00%-90.00%-
Source: S&P Global Market Intelligence.